Diflunisal

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C13H8F2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7C546U4DEN, chemically known as 5-(2,4-difluorophenyl)salicylic acid but generally known as diflunisal, which bears US NIH Compound Identifier 3059. European Medicines Agency schedules Diflunisal in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07130MIG. The term DIFLUNISAL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). World Health Organization schedules diflunisal in its Anatomical Therapeutic Chemical (ATC) Classification. DIFLUNISAL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule diflunisal under HS 29182980 and SITC 51394. As of Q4 2014, DIFLUNISAL remains the US FDA Preferred Term for this commodity. Diflunisal bears US NLM identifiers UMLS ID C0012228 and NCI Concept Code C47489. SMILES: FC1C(C2CC(C(O)CC2)C(=O)O)CCC(F)C1.